Development and validation of a personalized classifier to predict the prognosis and response to immunotherapy in glioma based on glycolysis and the tumor microenvironment.

Fan, Pengfei; Xia, Jinjin; Zhou, Meifeng; Zhuo, Chao; He, Hui

Fan, Pengfei; Xia, Jinjin; Zhou, Meifeng; Zhuo, Chao; He, Hui.

Affiliation

Fan P; Department of Neurology, Changxing People's Hospital, Huzhou, Zhejiang, China.
Xia J; Department of Neurology, Changxing People's Hospital, Huzhou, Zhejiang, China.
Zhou M; Department of Neurology, Changxing People's Hospital, Huzhou, Zhejiang, China.
Zhuo C; Department of Pediatrics, Changxing People's Hospital, Huzhou, Zhejiang, China.
He H; Department of Pediatrics, Changxing People's Hospital, Huzhou, Zhejiang, China.

PeerJ ; 11: e16066, 2023.

Article in En | MEDLINE | ID: mdl-37744243

Subject(s)

Glioma; Tumor Microenvironment; Humans; Tumor Microenvironment/genetics; Prognosis; Immunotherapy; Glioma/genetics; Glycolysis/genetics

Key words

Glioma; Glycolysis; Immunosuppressive microenvironment; KIF20A; Personalized classifier

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tumor Microenvironment / Glioma Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: PeerJ Year: 2023 Document type: Article Affiliation country: China Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google